0001628280-24-020789.txt : 20240506 0001628280-24-020789.hdr.sgml : 20240506 20240506181519 ACCESSION NUMBER: 0001628280-24-020789 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240502 FILED AS OF DATE: 20240506 DATE AS OF CHANGE: 20240506 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Craig Jeffery Michael CENTRAL INDEX KEY: 0001920469 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40537 FILM NUMBER: 24918943 MAIL ADDRESS: STREET 1: C/O BRIGHT HEALTH GROUP INC STREET 2: 8000 NORMAN CENTER DRIVE SUITE 1200 CITY: MINNEAPOLIS STATE: MN ZIP: 55437 FORMER NAME: FORMER CONFORMED NAME: Craig Jeff Michael DATE OF NAME CHANGE: 20220330 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NeueHealth, Inc. CENTRAL INDEX KEY: 0001671284 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 474991296 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9250 NW 36TH STREET STREET 2: SUITE 420 CITY: DORAL STATE: FL ZIP: 33178 BUSINESS PHONE: 612-238-1321 MAIL ADDRESS: STREET 1: 9250 NW 36TH STREET STREET 2: SUITE 420 CITY: DORAL STATE: FL ZIP: 33178 FORMER COMPANY: FORMER CONFORMED NAME: Bright Health Group Inc. DATE OF NAME CHANGE: 20210309 FORMER COMPANY: FORMER CONFORMED NAME: Bright Health Inc. DATE OF NAME CHANGE: 20160404 4 1 wk-form4_1715033709.xml FORM 4 X0508 4 2024-05-02 0 0001671284 NeueHealth, Inc. NEUE 0001920469 Craig Jeffery Michael C/O NEUEHEALTH, INC. 8000 NORMAN CENTER DRIVE, SUITE 900 MINNEAPOLIS MN 55437 0 1 0 0 GC & Corporate Secretary 0 Restricted Stock Units 2024-05-02 4 A 0 42000 0 A Common Stock 42000 42000 D Restricted Stock Units 2024-05-02 4 A 0 100000 0 A Common Stock 100000 100000 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. This grant was approved on March 11, 2024 by the Issuer's Compensation and Human Capital Committee as part of the Issuer's annual equity grants, subject to shareholder approval of an amendment to the Issuer's Amended and Restated 2021 Omnibus Incentive Plan, which approval was obtained on May 2, 2024. These restricted stock units vest in three equal annual installments beginning on March 11, 2025. This grant was approved on October 11, 2023 by the Issuer's Compensation and Human Capital Committee, subject to shareholder approval of an amendment to the Issuer's Amended and Restated 2021 Omnibus Incentive Plan, which approval was obtained on May 2, 2024. 100% of these restricted stock units vest on October 11, 2026. /s/Eric Halverson for Jeff Michael Craig, Attorney-in-Fact 2024-05-06